Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Clinical & Trials

    ALCOA+

    In one line
    Data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate (plus Complete, Consistent, Enduring, Available).
    Definition
    ALCOA+ is the data integrity framework regulators apply to clinical, manufacturing, and quality records. The '+' adds Complete, Consistent, Enduring, and Available to the original ALCOA principles. ALCOA stands for Attributable, Legible, Contemporaneous, Original and Accurate. Regulators including FDA, the MHRA and the WHO use these principles in data integrity guidance, and they apply to paper and electronic records alike. For electronic systems, the principles connect to 21 CFR Part 11 controls such as audit trails, access controls and validated systems.
    Why it matters
    Common in 21 CFR Part 11, EU Annex 11, and ISO 14155 audits. EHR exports, eCRF audit trails, and manual transcription practices are common ALCOA+ findings.
    Common pitfalls
    • •Failing to implement robust access controls can compromise the "Attributable" principle of ALCOA+.
    • •Inadequate validation of electronic systems can lead to data integrity issues, particularly concerning the "Accurate" and "Consistent" principles.
    • •Not maintaining comprehensive audit trails makes it difficult to prove data integrity over time, violating the "Complete" and "Enduring" principles.
    • •Assuming that commercial off-the-shelf software inherently meets ALCOA+ without proper configuration and validation is a common mistake.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.